Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-002480
Filing Date
2015-01-15
Accepted
2015-01-15 21:33:27
Documents
1
Period of Report
2013-08-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v398860_3.html 3  
1 OWNERSHIP DOCUMENT v398860_3.xml 3 6872
  Complete submission text file 0001144204-15-002480.txt   8560
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Issuer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1269 LAKESIDE DRIVE SUNNYVALE CA 94085
Business Address
COMMISSIONG JOHN WESLEY (Reporting) CIK: 0001619589 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55016 | Film No.: 15531103